2,044 results
·
20ms
·
Sources: EU EUDAMED, US FDA
Filters
Classification: FDA Class 3
×
Next Generation Sequencing Oncology Panel, Somatic Or Germline Variant Detection System
FDA Pre-Market Approval
FDA Class 3
·Oncomine Dx Target Test
Processor, Cervical Cytology Slide, Automated
FDA Pre-Market Approval
FDA Class 3
·THINPREP PROCESSORS
System, Test, Her-2/Neu, Ihc
FDA Pre-Market Approval
FDA Class 3
·DAKO HERCEPTEST
Next Generation Sequencing Oncology Panel, Somatic Or Germline Variant Detection System
FDA Pre-Market Approval
FDA Class 3
·FoundationOne Liquid CDx (F1 Liquid CDx)
Fluorescence In Situ Hybridization, Topoisomerase Ii Alpha, Gene Amplification And Deletion
FDA Pre-Market Approval
FDA Class 3
·DAKO TOP2A FISH PHARMDX KIT
Somatic Gene Mutation Detection System
FDA Pre-Market Approval
FDA Class 3
·LeukoStrat CDx FLT3 Mutation Assay
Reader, Cervical Cytology Slide, Automated
FDA Pre-Market Approval
FDA Class 3
·PAPNET (R) TESTING SYSTEM
Next Generation Sequencing Oncology Panel, Somatic Or Germline Variant Detection System
FDA Pre-Market Approval
FDA Class 3
·Oncomine Dx Target Test
Next Generation Sequencing Oncology Panel, Somatic Or Germline Variant Detection System
FDA Pre-Market Approval
FDA Class 3
·Oncomine Dx Target
Processor, Cervical Cytology Slide, Automated
FDA Pre-Market Approval
FDA Class 3
·PREPSTAIN SYSTEM/PREPMATE
Processor, Cervical Cytology Slide, Automated
FDA Pre-Market Approval
FDA Class 3
·MONOPREP PAP TEST
Next Generation Sequencing Oncology Panel, Somatic Or Germline Variant Detection System
FDA Pre-Market Approval
FDA Class 3
·myChoice CDx
Prostrate Cancer Genes Nucleic Acid Amplification Test System
FDA Pre-Market Approval
FDA Class 3
·PROGENSA PCA3 ASSAY
Processor, Cervical Cytology Slide, Automated
FDA Pre-Market Approval
FDA Class 3
·BD PREPSTAIN SYSTEM
Somatic Gene Mutation Detection System
FDA Pre-Market Approval
FDA Class 3
·cobas® EGFR Mutation Test
Test, Fluorescence In Situ Hybridization (Fish), For Bladder Cancer Detection And Monitoring For Recurrence
FDA Pre-Market Approval
FDA Class 3
·UROVYSION BLADDER CANCER KIT
Immunohistochemistry Assay, Antibody, Epidermal Growth Factor Receptor
FDA Pre-Market Approval
FDA Class 3
·EGFR pharmDx
Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer
FDA Pre-Market Approval
FDA Class 3
·HER2 CISH pharmDX Kit
Immunohistochemistry Antibody Assay, C-Kit
FDA Pre-Market Approval
FDA Class 3
·Pathway Anti-c-KIT (9.7) Rabbit Monoclonal Primary Antibody
Next Generation Sequencing Oncology Panel, Somatic Or Germline Variant Detection System
FDA Pre-Market Approval
FDA Class 3
·Guardant360 CDx